Found: 28
Select item for more details and to access through your institution.
Effectiveness of progressive dose-escalation of exenatide (exendin-4) in reducing dose-limiting side effects in subjects with type 2 diabetes.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2004, v. 20, n. 5, p. 411, doi. 10.1002/dmrr.499
- By:
- Publication type:
- Article
Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes: a dose-timing study.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2004, v. 20, n. 1, p. 55, doi. 10.1002/dmrr.419
- By:
- Publication type:
- Article
Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled study.
- Published in:
- European Journal of Endocrinology, 2000, v. 143, n. 5, p. 593
- By:
- Publication type:
- Article
Properties of pramlintide and insulin upon mixing.
- Published in:
- American Journal of Health-System Pharmacy, 2005, v. 62, n. 8, p. 816, doi. 10.1093/ajhp/62.8.816
- By:
- Publication type:
- Article
Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus.
- Published in:
- American Journal of Health-System Pharmacy, 2005, v. 62, n. 2, p. 173., doi. 10.1093/ajhp/62.2.173
- By:
- Publication type:
- Article
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials.
- Published in:
- Diabetologia, 2016, v. 59, n. 8, p. 1645, doi. 10.1007/s00125-016-3992-6
- By:
- Publication type:
- Article
First‐in‐human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrations.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 9, p. 2447, doi. 10.1111/dom.15066
- By:
- Publication type:
- Article
Metformin-associated lactic acidosis: Moving towards a new paradigm?
- Published in:
- 2017
- By:
- Publication type:
- Editorial
Exenatide Augments First- and Second-Phase Insulin Secretion in Response to Intravenous Glucose in Subjects with Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2005, v. 90, n. 11, p. 5991, doi. 10.1210/jc.2005-1093
- By:
- Publication type:
- Article
Synthetic Exendin-4 (Exenatide) Significantly Reduces Postprandial and Fasting Plasma Glucose in Subjects with Type 2 Diabetes.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2003, v. 88, n. 7, p. 3082, doi. 10.1210/jc.2002-021545
- By:
- Publication type:
- Article
Effects of Once-Weekly Dosing of a Long-Acting Release Formulation of Exenatide on Glucose Control and Body Weight in Subjects With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2007, v. 30, n. 6, p. 1487, doi. 10.2337/dc06-2375
- By:
- Publication type:
- Article
Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2005, v. 28, n. 5, p. 1092, doi. 10.2337/diacare.28.5.1092
- By:
- Publication type:
- Article
Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea.
- Published in:
- Diabetes Care, 2005, v. 28, n. 5, p. 1083, doi. 10.2337/diacare.28.5.1083
- By:
- Publication type:
- Article
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial.
- Published in:
- 2003
- By:
- Publication type:
- journal article
A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes.
- Published in:
- Diabetes Care, 2002, v. 25, n. 4, p. 724, doi. 10.2337/diacare.25.4.724
- By:
- Publication type:
- Article
Gestational diabetes mellitus is associated with an increase in the total concentration of amylin molecules.
- Published in:
- 1998
- By:
- Publication type:
- research
Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Mellitus.
- Published in:
- Journal of Clinical Pharmacology, 2008, v. 48, n. 12, p. 1389, doi. 10.1177/0091270008323750
- By:
- Publication type:
- Article
Pharmacokinetics of an Oral Drug (Acetaminophen) Administered at Various Times Relative to Subcutaneous Injection of Pramlintide in Subjects With Type 2 Diabetes.
- Published in:
- Journal of Clinical Pharmacology, 2007, v. 47, n. 7, p. 798, doi. 10.1177/0091270007300949
- By:
- Publication type:
- Article
Pharmacokinetics of an Oral Drug (Acetaminophen) Administered at Various Times in Relation to Subcutaneous Injection of Exenatide (Exendin-4) in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2005, v. 45, n. 5, p. 570, doi. 10.1177/0091270004274432
- By:
- Publication type:
- Article
Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Safety, Tolerability, and Pharmacokinetics of Same-Knee Intra-Articular Injection of Corticosteroid and Lorecivivint Within 7 Days: An Open-Label, Randomized, Parallel-Arm Study.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 6, p. 1741, doi. 10.1007/s40744-023-00604-7
- By:
- Publication type:
- Article
Effect of Pramlintide on Weight in Overweight and Obese Insulin-Treated Type 2 Diabetes Patients<sup>**</sup>.
- Published in:
- Obesity (19307381), 2004, v. 12, n. 4, p. 661, doi. 10.1038/oby.2004.76
- By:
- Publication type:
- Article
Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes.
- Published in:
- PLoS ONE, 2018, v. 13, n. 9, p. 1, doi. 10.1371/journal.pone.0203946
- By:
- Publication type:
- Article
The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies.
- Published in:
- 2016
- By:
- Publication type:
- journal article
1350-P: Safety and Pharmacokinetics of Technosphere Insulin in Pediatric Patients.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1350-P
- By:
- Publication type:
- Article
Spinal Disinhibition in Experimental and Clinical Painful Diabetic Neuropathy.
- Published in:
- 2017
- By:
- Publication type:
- journal article